Abstract
The molecular mechanism of striking higher prevalence of hepatocellular carcinoma (HCC) in male subjects has not yet been fully elucidated. Here, we report that androgen receptor (AR) is differentially expressed in different HCC cell lines. AR agonist dihydrotestosterone (DHT) enhances HCC cell growth and apoptotic resistance. Antagonist flutamide (FLU) blocks the effects of DHT on the HCC cell lines. Paternally expressed gene 10 (PEG10) is expressed in HCC cell lines at substantial high level. Using small interfering RNAs against AR and PEG10 in AR- and PEG10-expressing BEL-7404 hepatoma cells and HuH7 hepatoma cells (HuH7) cells, and AR-transfection technique in AR-lacking and PEG10-expressing HepG2 cells, we have confirmed that through upregulation and activation of PEG10, DHT enhances HCC cell growth and apoptotic resistance. We have further demonstrated that DHT upregulates expression of human telomerase reverse transcriptase (hTERT) in HCC cell lines in a PEG10-dependent manner. Moreover, AR directly interacts in vivo with androgen-responsive elements in the regions of promoter and exon 2 of PEG10 gene in HCC cell lines. DHT promotes the hepatoma formation in vivo nude mice through PEG10 activation. AR antagonists (FLU and valproate) inhibit the hepatoma formation. These findings suggest that PEG10 plays an essential role in hepatocarcinogenesis. The PEG10 inhibition can be a novel approach for therapy of HCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z et al. (2006). CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic Leukemia CD23+CD5+ B Cells. J Immunol 177: 6713–6722.
Death AK, McGrath KC, Handelsman DJ . (2005). Valproate is an anti-androgen and anti-progestin. Steroids 70: 946–953.
Greider CW . (1999). Telomerase activation: one-step on the road to cancer? Trends Genet 15: 109–112.
Huang R, Xing Z, Luan Z, Wu T, Wu X, Hu G . (2003). A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res 63: 3775–3782.
Jinquan T, Jacobi HH, Jing C, Millner A, Sten E, Hviid L et al. (2003). CCR3 expression induced by IL-2 and IL-4 functioning as a death receptor for B cells. J Immunol 171: 1722–1731.
Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ . (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 23: 222–226.
Komine F, Shimojima M, Moriyama M, Amaki S, Uchida T, Arakawa Y . (2000). Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgment of efficacy of treatment of small hepatocellular carcinoma. J Hepatol 132: 235–241.
Li CM, Margolin AA, Salas M, Memeo L, Mansukhani M, Hibshoosh H et al. (2006). PEG10 is a c-MYC target gene in cancer cells. Cancer Res 66: 665–672.
Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP . (2001). Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276: 13442–13451.
Massari P, Ho Y, Wetzler LM . (2000). Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis. Proc Natl Acad Sci USA 97: 9070–9075.
Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T . (1995). Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 82: 542–547.
Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y et al. (2003). Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 63: 3043–3048.
Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y et al. (2001). Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129–2137.
Ono R, Kobayashi S, Wagatsuma H, Aisaka K, Kohda T, Kaneko-Ishino T et al. (2001). A retrotransposon-derived gene, peg10, is a novel imprinted gene located on human chromosome 7q21. Genomics 73: 232–237.
Ono R, Nakamura K, Inoue K, Naruse M, Usami T, Wakisaka-Saito N et al. (2006). Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat Genet 38: 101–106.
Ramirez R, Carracedo J, Jimenez R, Canela A, Herrera E, Aljama P et al. (2003). Massive telomere loss is an early event of DNA damaged-induced apoptosis. J Biol Chem 278: 836–842.
Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE et al. (2005). Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene 24: 6773–6784.
Sathya G, Chang CY, Kazmin D, Cook CE, McDonnell DP . (2003). Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. Cancer Res 63: 8029–8036.
Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC et al. (2005). Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24–37.
Sica A, Saccani A, Borsatti A, Power CA, Wells TN, Luini W et al. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185: 969–974.
Steplewski A, Krynska B, Tretiakova A, Haas S, Khalili K, Amini S . (1998). MyEF-3, a developmentally controlled brain-derived nuclear protein which specifically interacts with myelin basic protein proximal regulatory sequences. Biochem Biophys Res Commun 243: 295–301.
Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK et al. (2003). Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 10: 625–635.
Youssef N, Paradis V, Ferlicot S, Bedossa P . (2001). In situ detection of telomerase enzymatic activity in human hepatocellular careinogenesis. J Pathol 194: 459–465.
Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM et al. (2001). Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 93: 1644–1651.
Zhang DY, Sabla G, Shivakumar P, Tiao G, Sokol RJ, Mack C et al. (2004). Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 39: 954–962.
Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D et al. (2005). The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci USA 102: 9890–9895.
Acknowledgements
This work was supported by National Natural Science Foundation of China (no. 39870674, 30572119, 30030130, 30471509, 30670937). Dr Tan Jinquan is a Chang Jiang Scholar supported by Chang Jiang Scholars Program from Ministry of Education, China and Li Ka Shing Foundation, Hong Kong, China.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jie, X., Lang, C., Jian, Q. et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26, 5741–5751 (2007). https://doi.org/10.1038/sj.onc.1210362
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210362
Keywords
This article is cited by
-
PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer
Journal of Experimental & Clinical Cancer Research (2017)
-
Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue
Scientific Reports (2017)
-
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
Oncogene (2014)
-
Specific changes in the expression of imprinted genes in prostate cancer—implications for cancer progression and epigenetic regulation
Asian Journal of Andrology (2012)
-
Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma
Pathology & Oncology Research (2011)